About Valneva SE

Company Description

Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The Company has several vaccines in development, including unique vaccines against Lyme disease, COVID-19 and chikungunya. Valneva’s portfolio also includes two commercial vaccines for travelers.

Year founded

2013

Served area

Worldwide

Headcount

762

Headquarters

6 Rue Alain Bombard, 44800 Saint-Herblain – France

Shareholder information

Shares outstanding

107,781,582

IPO

June 28, 2007

Stock exchange(s)

Euronext Paris

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.